- Investopedia•6 hours ago
Cytokinetics' spinal muscular atrophy drug, CK-2127107, improved muscle function in a pre-clinical study.
- GlobeNewswire•14 hours ago
SOUTH SAN FRANCISCO, Calif., March 22, 2017-- Cytokinetics, Inc. today announced that preclinical data for CK-2127107 were presented at the MDA Scientific Conference in Arlington, VA, showing that this ...
- GlobeNewswire•3 days ago
SOUTH SAN FRANCISCO, Calif., March 20, 2017-- Cytokinetics, Inc. today announced that additional results from COSMIC-HF, a Phase 2 trial evaluating omecamtiv mecarbil in patients with chronic heart failure, ...
CYTK : Summary for Cytokinetics, Incorporated - Yahoo Finance
Cytokinetics, Incorporated (CYTK)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
|Bid||3.00 x 300|
|Day's Range||12.20 - 12.85|
|52 Week Range||6.27 - 13.70|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||32.82|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|